Witness Testifies that Johnson & Johnson Hid Studies Showing Link to Diabetes and Risperdal

Bloomberg Businessweek reports that a witness has testified in a Texas jury trial that Johnson & Johnson officials hid three studies showing some patients using Riperdal developed diabetes while claiming the antipsychotic drug didn’t cause the disease.